DOCU vs FENC · P/E 15, rev $1.71B vs rev $17.9M
DocuSign Inc (DOCU) versus Fennec Pharmaceuticals Inc (FENC) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. FENC currently screens at market cap $302.2M.
Not investment advice. Open the DOCU and FENC stock pages for the full models.
Not investment advice.